Klinisk Biokemi i Norden · 2 2015
| 7
September 2
nd
, 8.00 am
Goldmining in Clinical Biochemistry - continued
8.00 – 8.45
Goldmining a new biomarker
Holger Jon Møller, MD, PhD, DMSc
Dept. of Clinical Biochemistry, Aarhus Univ.
Hospital, Denmark
8.55 – 9.40
Goldmining biobanks – The Copenhagen
General Population Study and the Copenha-
gen City Heart Study
Ruth Frikke-Schmidt, MD, PhD, DMSc
Dept. of Clinical Biochemistry
Rigshospitalet, Denmark
9.50 – 10.35
Goldmining the “omics” for biomarker dis-
covery
Niels H. H. Heegaard, MD, DMSc
Dept. of Autoimmunology and Biomarkers,
Statens Serum Institut, Denmark
P4 molecular medicine, genomics / metabolomics approaching the clinical laboratory
Arranged by Kristina Hotakainen, Finland
10.50 – 12.30
Break included
Personalized and precision health care:
impact on laboratory medicine
Olli Kallioniemi, MD, PhD,
Institute for Molecular Medicine Finland
FIMM, University of Helsinki, Finland
12.30 – 13.15 Lunch
13.15 – 14.55
Break included
Next-gen sequencing for genomics, transcrip-
tomics and epigenomics: future technology
trends with impact on diagnostics
Janna Saarela, MD, PhD,
Institute for Molecular Medicine Finland
FIMM, University of Helsinki, Finland
14.55 – 15.20 Coffee
15.20 – 17.00
Break included
Precision Medicine based on genomic insight,
examples from cancer, cardiology and endo-
crinology
Torben Falck Ørntoft, MD, DMSc
MOMA - Dept. of Molecular Medicine, Aarhus
University Hospital, Denmark
September 3
rd
, 8.00 am
Communication, dialogue, teaching, leadership
Arranged by Mattias Aldrimer, Sweden
8.00 – 8.45
Communication for Clinical Biochemists
Per Simonsson, MD, PhD
Siemens Healthcare Diagnostics AB, Sweden
9.00 – 10.40
Break included
Leadership and communication in a dynamic
organization
Anna-Marie Münster, MD, PhD Dept. of
Clinical Biochemistry, Hospitalsenheden Vest,
Denmark
10.55 – 12.30
Break included The leadership in a Laboratory Centre
Ivan Brandslund, MD, DMSc
Laboratory Centre
University of Southern Denmark & Lillebaelt
Hospital, Vejle, Denmark
➤➤
